Why this comparison matters
Hims, Ro, and Mochi Health are three of the most-searched telehealth GLP-1 programs in 2026. All three let you get a prescription online without visiting a clinic. But their approaches differ in ways that matter — pricing structures, which drugs they actually prescribe, how much clinical support you get, and whether they accept insurance.
This guide compares them on the dimensions real patients care about most so you can shortlist without scheduling three separate consultations. Every personal medication or dosing decision should involve your prescriber — we are comparing programs here, not recommending treatments.
The intake process
Hims keeps it simple. You fill out an asynchronous questionnaire — medical history, BMI, goals — and a provider reviews it without a live visit. Most patients receive a treatment decision within 24-48 hours. The speed is a genuine selling point: this is the fastest path from "I'm interested" to "medication shipped."
Ro Body requires a synchronous video consultation with a licensed provider. You discuss your history, current medications, labs, and goals in real time. The intake takes a few days to schedule, and the visit itself runs about 15-20 minutes. Slower than Hims, but more thorough.
Mochi Health also uses synchronous video visits, with an emphasis on matching you to an obesity-medicine-trained provider. Mochi's intake includes questions about body composition, previous weight loss attempts, and comorbidities. Expect 3-7 days from sign-up to your first appointment.
Medication options: brand vs. compounded, semaglutide vs. tirzepatide
This is where the three programs diverge sharply.
Hims primarily prescribes compounded semaglutide — a 503A pharmacy version of the active ingredient in Ozempic and Wegovy. As of early 2026, Hims does not prescribe brand-name Wegovy or Zepbound through its main weight loss program. Compounded medications are not FDA-approved for weight loss and are made by compounding pharmacies under different regulatory oversight than brand manufacturers. If you want tirzepatide (the dual GLP-1/GIP agonist), Hims is not currently the right fit.
Ro Body prescribes both brand-name GLP-1s (Wegovy, Zepbound, Ozempic off-label) and compounded semaglutide. Which you receive depends on your insurance, clinical profile, and current inventory. Ro's flexibility here is a genuine advantage — if your insurance covers Wegovy, they route you to the brand product. If it doesn't, they can fall back to compounded semaglutide. This brand-plus-compounded model means fewer dead ends during intake.
Mochi Health focuses on compounded semaglutide and compounded tirzepatide. Mochi was one of the first platforms to offer compounded tirzepatide (the active ingredient in Zepbound and Mounjaro), giving patients access to a dual-agonist even without insurance coverage for the brand product. If you specifically want tirzepatide at a self-pay price, Mochi is the standout option among these three.
Pricing comparison
All prices below reflect the self-pay (no insurance) cost as of April 2026. Prices change frequently — confirm directly before committing.
| | Hims | Ro Body | Mochi Health | |---|---|---|---| | Program / membership fee | Included in price | ~$99/mo | Included in price | | Compounded semaglutide | ~$199/mo | ~$145-$300/mo (dose-dependent) | ~$175/mo | | Compounded tirzepatide | Not offered | Not offered | ~$225/mo | | Brand-name GLP-1 | Not offered | Insurance + copay | Not offered | | Estimated self-pay total | ~$199/mo | ~$250-$450/mo | $175-$225/mo |
Hims sometimes runs promotional pricing for new patients. Ro's total is higher because the program fee stacks on top of medication cost, but insurance routing can dramatically reduce the effective price if you have coverage.
Clinical depth
This is where the programs diverge most in day-to-day experience.
Hims takes a streamlined approach. The initial consultation is asynchronous (a questionnaire reviewed by a provider). Ongoing support is primarily through in-app messaging. If you want minimal friction — fill out a form, get your prescription, auto-refill monthly — Hims delivers. However, if you want in-depth clinical conversations about dose adjustments, lab interpretation, or comorbidity management, you may find the experience thin. There is no routine lab monitoring built into the standard program.
Ro Body offers a middle ground. You get a synchronous video consultation with a licensed provider, and Ro's platform integrates with at-home lab testing (metabolic panels, A1c). They monitor markers over time and adjust your plan accordingly. The provider relationship feels more substantive than Hims, though it is still telehealth — not a long-term PCP relationship. Ro also offers weight-loss-specific content and tracking through its app.
Mochi Health positions itself as the most clinically intensive of the three. Visits are with obesity-trained providers (some are obesity medicine board-certified). Mochi tracks body composition, not just scale weight, and adjusts protocols based on lean mass retention. If you are concerned about muscle loss or want your provider to deeply understand GLP-1 pharmacology, Mochi is the strongest on clinical depth. Mochi's providers are also more likely to discuss resistance training and protein targets as part of your treatment plan.
Clinical depth ranking: Mochi > Ro > Hims.
The app and digital experience
Hims has a polished, consumer-grade app. Medication tracking, refill management, and provider messaging are all smooth. It feels like a subscription product — because it is. The app does not include structured coaching or behavior-change content.
Ro Body integrates lab results, medication tracking, weight logging, and provider communication into its app. The experience is more data-oriented than Hims, with metabolic trend charts and health insights. Ro also offers content on nutrition and exercise, though it is not a structured program.
Mochi Health has a functional app focused on provider communication, appointment scheduling, and body composition tracking. It is less polished than Hims or Ro from a design standpoint, but the clinical data integration (body composition, lean mass trends) is more detailed. Mochi's app reflects its clinical-first ethos — substance over polish.
Insurance support
Hims: Self-pay only for GLP-1 weight loss. No insurance billing. This keeps the process fast but means you pay full price regardless of your coverage.
Ro Body: Accepts insurance for brand-name GLP-1s where coverage exists. Self-pay for compounded formulations. Ro handles prior authorizations and will check your coverage during intake before you commit. This is a meaningful advantage — if your employer plan covers Wegovy, Ro can get you brand-name semaglutide at your copay rate.
Mochi Health: Primarily self-pay. Some plans offer insurance navigation assistance, but the core program is out-of-pocket. Mochi's value proposition is affordable compounded access, not insurance routing.
Speed of access
How fast can you go from sign-up to medication in hand?
- Hims: 2-5 days. Fastest of the three. Asynchronous intake means no scheduling delays.
- Ro Body: 5-10 days. Video visit scheduling adds time, and insurance verification can add a few more days if you are going the brand-name route.
- Mochi Health: 5-10 days. Similar to Ro. The synchronous visit and provider matching process takes a few days.
If speed is your top priority and you want compounded semaglutide, Hims is the clear winner.
Customer support
Hims handles most support through in-app messaging and chat. Response times are generally fast (same day). Phone support exists but is not emphasized.
Ro Body offers in-app messaging to your provider plus a separate care support team for logistics (shipping, billing, insurance). The dual-layer support model means clinical questions go to your doctor, logistical questions go to the support team.
Mochi Health emphasizes direct provider access. You can message your prescriber between appointments, and many patients report faster clinical response times than Hims or Ro. Logistical support is less polished — Mochi is a smaller company and it shows in the operational layer.
Pick this one if...
Choose Hims if you want the fastest, most friction-free path to compounded semaglutide at a competitive price. You are a healthy adult with straightforward weight loss goals. You do not need extensive clinical guidance. You want a subscription that just works.
Choose Ro if you want the flexibility to use insurance for brand-name GLP-1s, or you value a video-based provider relationship with integrated lab monitoring. Ro is the best choice if you have insurance coverage for Wegovy or Zepbound and want to use it. It is also the right pick if you want brand-name medication under full FDA manufacturing oversight.
Choose Mochi if clinical depth matters most — you want an obesity medicine specialist, you are concerned about muscle loss, or you specifically want compounded tirzepatide. Mochi is the strongest choice for patients who want their telehealth provider to think like an obesity medicine doctor, not a prescription vending machine.
What about switching?
Switching between programs is straightforward in most cases. Your medical records are yours — you can request them from any provider. The main friction points are:
- Dose continuity: Make sure your new provider knows your current dose and titration history.
- Compounded vs. brand: If you switch from compounded to brand (or vice versa), your provider should re-titrate from a clinically appropriate starting point. Consult your prescriber on safe transitions.
- Prescription timing: Plan a 2-3 week overlap to avoid gaps in medication.
Our bottom line
There is no universally "best" program — it depends on what you are optimizing for. Hims wins on speed and simplicity. Ro wins on flexibility (brand + compounded, insurance + self-pay). Mochi wins on clinical depth and access to compounded tirzepatide.
If budget and speed are the primary constraints, start with Hims. If you have insurance that might cover Wegovy or Zepbound, start with Ro — the savings can be substantial. If you want the most medically intensive experience and are willing to pay for it, start with Mochi.
All three are legitimate programs with licensed providers. The right choice depends on your insurance situation, medication preference, and how much clinical support you want. When in doubt, consult a prescriber about which medication and program structure fits your health profile.